Two Sigma Investments, LP Incyte Corp Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Incyte Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 20,584 shares of INCY stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,584

Previous 218,083 90.56%

Holding current value

$1.48 Million

Previous $13.2 Million 89.71%

% of portfolio

0.0%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $11.3 Million - $13.6 Million	-197,499 Reduced 90.56%	20,584 $1.36 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $42.8 Million - $53.3 Million	-836,405 Reduced 79.32%	218,083 $13.2 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $48.5 Million - $57.1 Million	-857,299 Reduced 44.84%	1,054,488 $60.1 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $14 Million - $17.2 Million	268,098 Added 16.31%	1,911,787 $120 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $26.6 Million - $30.4 Million	-460,985 Reduced 21.9%	1,643,689 $95 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $92.2 Million - $114 Million	1,513,339 Added 255.92%	2,104,674 $131 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $13.9 Million - $17.1 Million	198,238 Added 50.43%	591,335 $42.7 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $22.3 Million - $28 Million	332,599 Added 549.77%	393,097 $31.6 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $21.2 Million - $26.5 Million	-319,601 Reduced 84.08%	60,498 $4.03 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $11.8 Million - $14.8 Million	-178,186 Reduced 31.92%	380,099 $28.9 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $36.9 Million - $44.5 Million	558,285 New	558,285 $44.3 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $1.23 Million - $1.62 Million	-16,163 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $13.2 Million - $16 Million	-164,028 Reduced 91.03%	16,163 $1.41 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $10.7 Million - $13.8 Million	125,457 Added 229.21%	180,191 $16.2 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $7.1 Million - $10.4 Million	-95,742 Reduced 63.63%	54,734 $5.69 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $45.8 Million - $62.4 Million	-725,541 Reduced 82.82%	150,476 $11 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $44.6 Million - $58.5 Million	610,778 Added 230.27%	876,017 $76.5 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $46.3 Million - $55 Million	-635,158 Reduced 70.54%	265,239 $19.7 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $6.23 Million - $7.52 Million	84,744 Added 10.39%	900,397 $76.5 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $25.2 Million - $34.9 Million	-395,860 Reduced 32.67%	815,653 $70.2 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $33.2 Million - $39.7 Million	567,826 Added 88.21%	1,211,513 $77 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $39.7 Million - $47.8 Million	643,687 New	643,687 $44.5 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $8.79 Million - $12.1 Million	-144,460 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $48.6 Million - $59 Million	-584,647 Reduced 80.19%	144,460 $12 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $39.9 Million - $49.7 Million	426,181 Added 140.69%	729,107 $69.1 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $33.1 Million - $41.9 Million	302,926	302,926 $35.4 Million

Others Institutions Holding INCY

# of Institutions

649

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Incyte Corp Transaction History